Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-03 Tasse Daniel Director Grant or award · Stock Option (Right to Buy) +15,324 15,324
2022-06-03 STUMP DAVID C Director Grant or award +3,010 3,010
2022-06-03 STUMP DAVID C Director Grant or award · Stock Option (Right to Buy) +15,324 15,324
2022-06-03 MIGAUSKY GEORGE V Director Grant or award +3,010 3,010
2022-06-03 MIGAUSKY GEORGE V Director Grant or award · Stock Option (Right to Buy) +15,324 15,324
2022-06-03 KARABELAS ARGERIS N Director Grant or award +3,010 3,010
2022-06-03 KARABELAS ARGERIS N Director Grant or award · Stock Option (Right to Buy) +15,324 15,324
2022-06-03 Glucksmann Alexandra Director Grant or award +3,010 3,010
2022-06-03 Glucksmann Alexandra Director Grant or award · Stock Option (Right to Buy) +15,324 15,324
2022-06-03 Fox Allan M. Director Grant or award +3,010 3,010
2022-06-03 Fox Allan M. Director Grant or award · Stock Option (Right to Buy) +15,324 15,324
2022-06-03 Bennett Jean Director Grant or award +3,010 3,010
2022-06-03 Bennett Jean Director Grant or award · Stock Option (Right to Buy) +15,324 15,324
2022-01-20 Vasista Vittal Chief Financial Officer Option exercise +29,900 $0.85 $25K 162,440
2022-01-20 Vasista Vittal Chief Financial Officer Option exercise · Employee Stock Option (Right to Buy) −29,900 35,000
2022-01-03 Vasista Vittal Chief Financial Officer Grant or award +8,900 132,540
2022-01-03 Vasista Vittal Chief Financial Officer Grant or award · Stock Option (Right to Buy) +42,500 42,500
2022-01-03 Simpson Curran Chief Oper. & Tech. Officer Grant or award +10,700 27,116
2022-01-03 Simpson Curran Chief Oper. & Tech. Officer Grant or award · Stock Option (Right to Buy) +51,100 51,100
2022-01-03 PAKOLA STEVE Chief Medical Officer Sale −1,598 $33.75 $54K 8,250

Page 14 of 25 · 494 trades